KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Diluted Average) (2019 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Shares Outstanding (Diluted Average) for 5 consecutive years, with $48.3 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Shares Outstanding (Diluted Average) fell 97.04% year-over-year to $48.3 million, compared with a TTM value of $48.3 million through Sep 2023, down 97.04%, and an annual FY2022 reading of $42.0 million, down 96.91% over the prior year.
  • Shares Outstanding (Diluted Average) was $48.3 million for Q3 2023 at Ginkgo Bioworks Holdings, down from $1.9 billion in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $1.9 billion in Q2 2023 and bottomed at $1.6 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $1.1 billion, with a median of $1.3 billion recorded in 2021.
  • Peak annual rise in Shares Outstanding (Diluted Average) hit 119130.92% in 2023, while the deepest fall reached 97.04% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $1.1 billion in 2019, then rose by 10.95% to $1.3 billion in 2020, then rose by 6.72% to $1.4 billion in 2021, then tumbled by 96.91% to $42.0 million in 2022, then grew by 15.08% to $48.3 million in 2023.
  • Business Quant data shows Shares Outstanding (Diluted Average) for DNA at $48.3 million in Q3 2023, $1.9 billion in Q2 2023, and $1.9 billion in Q1 2023.